UBS Sets BioAge Labs Price Target at $8 per Share
UBS initiated coverage of BioAge Labs at Neutral, according to Benzinga.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.